BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 18043555)

  • 1. Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
    Pekova L; Shomov G; Mladenova I; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):383-6. PubMed ID: 18043555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infections with Clostridium difficile following antibiotic therapy].
    Scheppach W
    MMW Fortschr Med; 2009 Oct; 151(40):47-9. PubMed ID: 19927920
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
    Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
    Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relapsing infections with Clostridium difficile].
    Visser WE; Dingemans-Dumas AM; Bac DJ
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.
    Simor AE
    J Am Geriatr Soc; 2010 Aug; 58(8):1556-64. PubMed ID: 20646106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Dec; 54(47):1201-5. PubMed ID: 16319813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile small-bowel enteritis after total proctocolectomy: a rare but fatal, easily missed diagnosis. Report of a case.
    Kim KA; Wry P; Hughes E; Butcher J; Barbot D
    Dis Colon Rectum; 2007 Jun; 50(6):920-3. PubMed ID: 17468989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
    Pituch H; Obuch-Woszczatyński P; Glinka D; Łazińska B; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(3):253-8. PubMed ID: 14702667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
    Bakken JS
    Minn Med; 2009 Jul; 92(7):38-40. PubMed ID: 19708314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
    Pépin J; Routhier S; Gagnon S; Brazeau I
    Clin Infect Dis; 2006 Mar; 42(6):758-64. PubMed ID: 16477549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile-associated colitis.
    Hull MW; Beck PL
    Can Fam Physician; 2004 Nov; 50():1536-40, 1543-5. PubMed ID: 15597970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M
    An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Pepin J
    Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
    Schweitzer MA; Sweiss I; Silver DL; Stellato TA
    Am Surg; 1996 Jul; 62(7):603-7; discussion 607-8. PubMed ID: 8651560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.